{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:12:05Z","timestamp":1775081525625,"version":"3.50.1"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T00:00:00Z","timestamp":1343088000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001729","type":"journal-article","created":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T21:32:57Z","timestamp":1343165577000},"page":"e1729","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":18,"title":["Ascorbic Acid Has Superior Ex Vivo Antiproliferative, Cell Death-Inducing and Immunomodulatory Effects over IFN-\u03b1 in HTLV-1-Associated Myelopathy"],"prefix":"10.1371","volume":"6","author":[{"given":"Britta","family":"Moens","sequence":"first","affiliation":[]},{"given":"Daniele","family":"Decanine","sequence":"additional","affiliation":[]},{"given":"Soraya Maria","family":"Menezes","sequence":"additional","affiliation":[]},{"given":"Ricardo","family":"Khouri","sequence":"additional","affiliation":[]},{"given":"Gilvan\u00e9ia","family":"Silva-Santos","sequence":"additional","affiliation":[]},{"given":"Giovanni","family":"Lopez","sequence":"additional","affiliation":[]},{"given":"Carolina","family":"Alvarez","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Talledo","sequence":"additional","affiliation":[]},{"given":"Eduardo","family":"Gotuzzo","sequence":"additional","affiliation":[]},{"given":"Ramon","family":"de Almeida Kruschewsky","sequence":"additional","affiliation":[]},{"given":"Bernardo","family":"Galv\u00e3o-Castro","sequence":"additional","affiliation":[]},{"given":"Anne-Mieke","family":"Vandamme","sequence":"additional","affiliation":[]},{"given":"Johan","family":"Van Weyenbergh","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2012,7,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00042560-199802010-00011","article-title":"Incidence of HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Jamaica and Trinidad.","volume":"17","author":"EM Maloney","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/13550280260422668","article-title":"Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM\/TSP).","volume":"8","author":"M Osame","year":"2002","journal-title":"J Neurovirol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1086\/344269","article-title":"Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease.","volume":"186","author":"S Jacobson","year":"2002","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/ana.10065","article-title":"Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM\/TSP.","volume":"50","author":"M Nagai","year":"2001","journal-title":"Annals of neurology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ana.20126","article-title":"Human T-lymphotropic virus type II and neurological disease.","volume":"56","author":"A Araujo","year":"2004","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/WNL.46.4.1016","article-title":"Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial.","volume":"46","author":"S Izumo","year":"1996","journal-title":"Neurology"},{"key":"ref7","first-page":"282","article-title":"[Intermittent high-dose vitamin C therapy in patients with HTLV-I-associated myelopathy].","volume":"33","author":"A Kataoka","year":"1993","journal-title":"Rinsho Shinkeigaku"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/13550289609146899","article-title":"Therapeutic trials in 200 patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis.","volume":"2","author":"M Nakagawa","year":"1996","journal-title":"J Neurovirol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1476-5381.2009.00282.x","article-title":"Vitamin C: update on physiology and pharmacology.","volume":"157","author":"J Mandl","year":"2009","journal-title":"British journal of pharmacology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1073\/pnas.75.9.4538","article-title":"Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer.","volume":"75","author":"E Cameron","year":"1978","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00280-010-1418-6","article-title":"Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs.","volume":"67","author":"A Fromberg","year":"2011","journal-title":"Cancer chemotherapy and pharmacology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/annonc\/mdn377","article-title":"Phase I clinical trial of i.v. ascorbic acid in advanced malignancy.","volume":"19","author":"LJ Hoffer","year":"2008","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology\/ESMO"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1079\/PNS19990012","article-title":"Effects of dietary antioxidants on the immune function of middle-aged adults.","volume":"58","author":"DA Hughes","year":"1999","journal-title":"The Proceedings of the Nutrition Society"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.","volume":"347","author":"MW Fried","year":"2002","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood-2009-06-195370","article-title":"How I treat hairy cell leukemia.","volume":"115","author":"MR Grever","year":"2010","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend or foe?","volume":"207","author":"G Trinchieri","year":"2010","journal-title":"The Journal of experimental medicine"},{"key":"ref17","first-page":"289","article-title":"Ascorbic acid induces apoptosis in adult T-cell leukemia.","volume":"27","author":"S Harakeh","year":"2007","journal-title":"Anticancer research"},{"key":"ref18","first-page":"997","article-title":"Transformation of normal human cord lymphocytes by co-cultivation with a lethally irradiated human T-cell line carrying type C virus particles.","volume":"72","author":"I Miyoshi","year":"1981","journal-title":"Gann"},{"key":"ref19","first-page":"978","article-title":"A T-cell line derived from normal human cord leukocytes by co-culturing with human leukemic T-cells.","volume":"72","author":"I Miyoshi","year":"1981","journal-title":"Gann\u200a=\u200aGan"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1089\/08892220050193191","article-title":"High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells.","volume":"16","author":"E Hanon","year":"2000","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"9716","DOI":"10.1128\/JVI.77.17.9716-9722.2003","article-title":"High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.","volume":"77","author":"PK Goon","year":"2003","journal-title":"Journal of virology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2334-4-7","article-title":"Exacerbated inflammatory cellular immune response characteristics of HAM\/TSP is observed in a large proportion of HTLV-I asymptomatic carriers.","volume":"4","author":"SB Santos","year":"2004","journal-title":"BMC infectious diseases"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0022-510X(90)90217-B","article-title":"Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy\/tropical spastic paraparesis.","volume":"97","author":"N Nishimoto","year":"1990","journal-title":"Journal of the neurological sciences"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"13389","DOI":"10.1128\/JVI.77.24.13389-13395.2003","article-title":"Alpha interferon inhibits human T-cell leukemia virus type 1 assembly by preventing Gag interaction with rafts.","volume":"77","author":"X Feng","year":"2003","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1128\/JVI.64.11.5682-5687.1990","article-title":"In vivo cellular tropism of human T-cell leukemia virus type 1.","volume":"64","author":"JH Richardson","year":"1990","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2174\/156802611796235107","article-title":"Dietary antioxidants: immunity and host defense.","volume":"11","author":"MA Puertollano","year":"2011","journal-title":"Current topics in medicinal chemistry"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1038\/sj.onc.1208978","article-title":"Molecular mechanisms of cellular transformation by HTLV-1 Tax.","volume":"24","author":"R Grassmann","year":"2005","journal-title":"Oncogene"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/10428190701760060","article-title":"Increased microvessel density in involved organs from patients with HTLV-I associated adult T cell leukemia lymphoma.","volume":"49","author":"G Kchour","year":"2008","journal-title":"Leukemia & lymphoma"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.1016\/j.febslet.2007.10.008","article-title":"IL-2 withdrawal induces HTLV-1 expression through p38 activation in ATL cell lines.","volume":"581","author":"M Washiyama","year":"2007","journal-title":"FEBS letters"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10495-008-0289-3","article-title":"HTLV-1 Tax protein cooperates with Ras in protecting cells from apoptosis.","volume":"14","author":"N Vajente","year":"2009","journal-title":"Apoptosis : an international journal on programmed cell death"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1038\/sj.onc.1208825","article-title":"Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells.","volume":"24","author":"SJ Jeong","year":"2005","journal-title":"Oncogene"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2169\/internalmedicine.46.6118","article-title":"Blockade of IL-2 receptor suppresses HTLV-I and IFN-gamma expression in patients with HTLV-I-associated myelopathy\/tropical spastic paraparesis.","volume":"46","author":"N Fukushima","year":"2007","journal-title":"Internal medicine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.4049\/jimmunol.163.7.4064","article-title":"Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy\/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2\/15R beta receptor.","volume":"163","author":"N Azimi","year":"1999","journal-title":"Journal of immunology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000097259","article-title":"Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1.","volume":"13","author":"SB Santos","year":"2006","journal-title":"Neuroimmunomodulation"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2249.2006.03208.x","article-title":"Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Peru.","volume":"146","author":"I Best","year":"2006","journal-title":"Clinical and experimental immunology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1182\/blood.V99.9.3335","article-title":"High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy\/tropical spastic paraparesis.","volume":"99","author":"PK Goon","year":"2002","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/00005072-199401000-00009","article-title":"Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy.","volume":"53","author":"F Umehara","year":"1994","journal-title":"Journal of neuropathology and experimental neurology"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0165-5728(93)90014-P","article-title":"Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy.","volume":"42","author":"Y Kuroda","year":"1993","journal-title":"Journal of neuroimmunology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0165-5728(93)90001-F","article-title":"Detection of tumor necrosis factor-alpha-positive cells in cerebrospinal fluid of patients with HTLV-I-associated myelopathy.","volume":"42","author":"S Nakamura","year":"1993","journal-title":"Journal of neuroimmunology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/432058","article-title":"Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy\/tropical spastic paraparesis in childhood and adolescence.","volume":"41","author":"JR Primo","year":"2005","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jpeds.2009.05.027","article-title":"Early neurologic abnormalities associated with human T-cell lymphotropic virus type 1 infection in a cohort of Peruvian children.","volume":"155","author":"EA Kendall","year":"2009","journal-title":"The Journal of pediatrics"},{"key":"ref42","first-page":"449","article-title":"The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV.","volume":"115","author":"N Manel","year":"2003"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-4690-8-19","article-title":"ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells.","volume":"8","author":"K Hagiya","year":"2011","journal-title":"Retrovirology"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1073\/pnas.0507631103","article-title":"HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.","volume":"103","author":"Y Satou","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1182\/blood-2008-04-154286","article-title":"Human T-cell leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte proliferation.","volume":"112","author":"J Arnold","year":"2008","journal-title":"Blood"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1742-4690-6-19","article-title":"In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP).","volume":"6","author":"M Saito","year":"2009","journal-title":"Retrovirology"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"8328","DOI":"10.1128\/JVI.00570-11","article-title":"Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression.","volume":"85","author":"L Wang","year":"2011","journal-title":"Journal of virology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.semcancer.2008.01.008","article-title":"miRNAs: Little known mediators of oncogenesis.","volume":"18","author":"AL Gartel","year":"2008","journal-title":"Seminars in cancer biology"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1139253","article-title":"Requirement of bic\/microRNA-155 for normal immune function.","volume":"316","author":"A Rodriguez","year":"2007","journal-title":"Science"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2010.09.009","article-title":"MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development.","volume":"33","author":"RM O'Connell","year":"2010","journal-title":"Immunity"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.4049\/jimmunol.1003952","article-title":"Silencing microRNA-155 ameliorates experimental autoimmune encephalomyelitis.","volume":"187","author":"G Murugaiyan","year":"2011","journal-title":"Journal of immunology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"8695","DOI":"10.3390\/ijms12128695","article-title":"Genetic association and altered gene expression of mir-155 in multiple sclerosis patients.","volume":"12","author":"EM Paraboschi","year":"2011","journal-title":"International journal of molecular sciences"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1093\/brain\/awp300","article-title":"MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.","volume":"132","author":"A Junker","year":"2009","journal-title":"Brain : a journal of neurology"},{"key":"ref54","article-title":"MiR-155 regulates IFN-gamma production in natural killer cells.","author":"R Trotta","year":"2012","journal-title":"Blood"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1742-4690-5-100","article-title":"MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes.","volume":"5","author":"K Pichler","year":"2008","journal-title":"Retrovirology"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1182\/blood-2008-11-189845","article-title":"Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia.","volume":"113","author":"M Bellon","year":"2009","journal-title":"Blood"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001729","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T16:57:20Z","timestamp":1687625840000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001729"}},"subtitle":[],"editor":[{"given":"Edgar M.","family":"Carvalho","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2012,7,24]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001729","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,24]]}}}